• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Archives of cardiovascular diseases. Supplements >Atrial fibrillation and myocardial infarction: An increased risk of mortality [Fibrillation atriale et infarctus du myocarde: Un risque accru de mortalité]
【24h】

Atrial fibrillation and myocardial infarction: An increased risk of mortality [Fibrillation atriale et infarctus du myocarde: Un risque accru de mortalité]

机译：心房纤颤和心肌梗塞：死亡风险增加[心房纤颤和心肌梗塞：死亡风险增加]

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Atrial fibrillation is a common finding in patients with myocardial infarction, its incidence vanes between 4% and 25% in the acute phase of myocardial infarction. The présence of atrial fibrillation is associated with an increased risk of mortality in patients with a myocardial infarction, even after adjustment for several important atrial fibrillation risk factors and regardless of the timing of onset of atrial fibrillation. This subsequent 40% increase in mortality associated with atrial fibrillation during myocardial infarction suggests that closer attention should be paid to these patients. Further research is needed to identify ways to prevent the occurrence of atrial fibrillation during myocardial infarction and to determine the optimal atrial fibrillation therapeutics strategies to reduce mortality in patients with myocardial infarction.
机译：心房纤颤是心肌梗死患者的常见发现，在心肌梗死急性期其发生率在4％至25％之间。心房纤颤的存在与心肌梗死患者的死亡风险增加相关，即使在调整了几个重要的心房纤颤危险因素之后，无论心房纤颤的发作时间如何。随后在心肌梗死时与心房颤动有关的死亡率增加40％，表明应更加关注这些患者。需要进一步的研究来确定预防心肌梗死期间房颤发生的方法，并确定降低心梗患者死亡率的最佳房颤治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号